Fast Five Quiz: Early Non–Small Cell Lung Cancer

Daniel S. Schwartz, MD

Disclosures

May 24, 2022

The NCCN recommends postoperative chemotherapy for high-risk, margin-negative, stage IB disease. However, this course of treatment is disfavored for patients with resected 1A NSCLC.

In patients with completely resected NSCLC, adjuvant chemotherapy has improved survival in patients with early-stage disease.

Learn more about treatment of NSCLC.

Editor's Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....